Market Intel: CGM Market Competition And Device Interoperability Were Hot Topics At ADA2019

Device interoperability and the increased use of continuous glucose monitoring (CGM) dominated much of the discussion at this year's annual American Diabetes Association meeting in San Francisco. Several major CGM players, including Dexcom Inc., Abbott Laboratories Inc., Medtronic PLC and Senseonics Holdings Inc., made big announcements and presented new data, giving conference attendees and the marketplace a lot to talk about.

On the insulin delivery front, Tandem Diabetes Care Inc. presented positive data on its Control-IQ algorithm that uses the first US Food and Drug Administration-approved interoperable Dexcom G6 CGM as well as the first interoperable insulin pump, the t:slim X2, for which it received de novo clearance from the FDA in February